Shimadzu (Kyoto, Japan) has announced the release of the LCMS-8060NX, a new liquid chromatograph mass spectrometer. The LCMS-8060NX aims to deliver high levels of sensitivity, detection speeds, ease of use and robustness when preparing and analyzing scientific samples.
At ASMS 2020 Reboot, SCIEX (MA, USA) presented the new Echo® MS system. The system, which uses a proprietary acoustic ejection technology, promises ultrahigh throughput and high-quality data.
At the virtual ASMS 2020 Reboot conference, Bruker (MA, USA) announced the first commercially available matrix-assisted laser desorption ionization-2 (MALDI-2) source, along with the innovations in Bruker’s proteomics platforms.
Scientists from the University of Birmingham (UK) are in the process of developing a new blood test that could facilitate earlier and more accurate prostate cancer detection.
Thermo Fisher Scientific (MA, USA) has expanded its Orbitrap platform with the release of new software functionalities and two new generation high-resolution mass spectrometers, which are being showcased at ASMS 2020 Reboot.
Scientists have reported a blood biomarker test that could be used to identify individuals with multiple sclerosis whose condition is likely to deteriorate in the following year.
Scientists from Prokhorov General Physics Institute of the Russian Academy of Sciences (Moscow, Russia) and the Moscow Institute of Physics and Technology (Russia) have developed a new tool to that could improve the diagnosis and monitoring of autoimmune disorders.
Thermo Fisher Scientific (MA, USA), WuXi Diagnostics (Shanghai, China) and Mayo Clinic (MN, USA) are collaborating to develop and validate a serology test for COVID-19.
Emergency use authorization for Thermo Fisher Scientific’s COVID-19 diagnostic test expanded by US FDA
The US FDA has expanded the emergency use authorization granted to Thermo Fisher Scientific’s (MA, USA) COVID-19 diagnostic test. The expansion could facilitate workflow flexibility and increase test throughput.
Researchers have developed a tool that could help to monitor the spread of infectious diseases. The newly developed blood test could provide information about whether and when an individual has been exposed to infection.